Azimuth Capital Management buys $10.4 Million stake in West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST) : Azimuth Capital Management scooped up 41,081 additional shares in West Pharmaceutical Services during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 144,940 shares of West Pharmaceutical Services which is valued at $10.4 Million.West Pharmaceutical Services makes up approximately 0.99% of Azimuth Capital Management’s portfolio.

Other Hedge Funds, Including , Bessemer Group Inc reduced its stake in WST by selling 72 shares or 0.81% in the most recent quarter. The Hedge Fund company now holds 8,869 shares of WST which is valued at $635,553.Manufacturers Life Insurance Company The boosted its stake in WST in the latest quarter, The investment management firm added 3,125 additional shares and now holds a total of 140,815 shares of West Pharmaceutical Services which is valued at $10.1 Million. West Pharmaceutical Services makes up approx 0.02% of Manufacturers Life Insurance Company The’s portfolio.Bahl Gaynor Inc reduced its stake in WST by selling 144 shares or 0.38% in the most recent quarter. The Hedge Fund company now holds 37,544 shares of WST which is valued at $2.7 Million. West Pharmaceutical Services makes up approx 0.04% of Bahl Gaynor Inc’s portfolio.Ls Investment Advisors boosted its stake in WST in the latest quarter, The investment management firm added 225 additional shares and now holds a total of 2,878 shares of West Pharmaceutical Services which is valued at $206,237. West Pharmaceutical Services makes up approx 0.02% of Ls Investment Advisors’s portfolio.Tiaa Cref Investment Management reduced its stake in WST by selling 17,391 shares or 5.63% in the most recent quarter. The Hedge Fund company now holds 291,673 shares of WST which is valued at $20.5 Million. West Pharmaceutical Services makes up approx 0.02% of Tiaa Cref Investment Management’s portfolio.

West Pharmaceutical Services opened for trading at $71.57 and hit $73.56 on the upside on Monday, eventually ending the session at $73.24, with a gain of 2.20% or 1.58 points. The heightened volatility saw the trading volume jump to 5,17,554 shares. Company has a market cap of $5,352 M.

On the company’s financial health, West Pharmaceutical Services reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.51. The company had revenue of $362.10 million for the quarter, compared to analysts expectations of $356.32 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.

Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Initiated by Wells Fargo to “Outperform” on Mar 22, 2016.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Leave a Reply

West Pharmaceutical Services - Is it time to Sell?

Top Brokerage Firms are advising their investors on West Pharmaceutical Services. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.